Microbot Medical Expands into North Carolina with First LIBERTY Robotic System Adoption

Event summary

  • Microbot Medical Inc. has secured its first healthcare system customer in North Carolina for the LIBERTY® Endovascular Robotic System.
  • The adoption expands the company's geographic footprint into the Southeast, Mid-Atlantic, and Northeast U.S.
  • The new account is part of a multi-hospital network covering the entire state of North Carolina.
  • Harel Gadot, CEO, President, and Chairman of Microbot Medical, highlighted the increasing pace of new account additions post-full market release of the LIBERTY system.

The big picture

Microbot Medical's expansion into North Carolina marks a strategic milestone in its commercial strategy, demonstrating the growing acceptance of its LIBERTY® Endovascular Robotic System among leading healthcare systems. This adoption is part of a broader trend of robotic technology transforming endovascular procedures, positioning Microbot Medical as a key player in the medical device industry. The company's focus on precision, efficiency, and safety through advanced robotic technology aligns with the increasing demand for innovative solutions in endovascular care.

What we're watching

Market Penetration
How the adoption in North Carolina will affect Microbot Medical's ability to penetrate other major metropolitan markets.
Competitive Dynamics
Whether the company can sustain its growth trajectory as more leading academic institutions adopt the LIBERTY system.
Regulatory Compliance
The pace at which Microbot Medical can navigate regulatory pathways and secure approvals for future versions of the LIBERTY system.